Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and CyclophosphamidePaola Papaldo, F. Calabresi, Massimo Lopez et al.|Journal of Clinical Oncology|2005Cited by 96
Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and CyclophosphamidePaola Papaldo, Paolo Marolla, Massimo Lopez et al.|Journal of Clinical Oncology|2003Cited by 76
Hormonal Treatment of Disseminated Male Breast CancerMassimo Lopez, Paola Papaldo, Luigi Di Lauro et al.|Oncology|2009Cited by 57
Does Granulocyte Colony-Stimulating Factor Worsen Anemia in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide?Paola Papaldo, Francesco Cognetti, Mauro Antimi et al.|Journal of Clinical Oncology|2006Cited by 42
Chemotherapy in Metastatic Male Breast CancerMassimo Lopez, Bonaventura Lazzaro, Luigi Di Lauro et al.|Oncology|2009Cited by 33